SCHEMBL19911342

SCHEMBL19911342

COc1ccc2c(c1)ncn2C(=O)C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.48
FGFR1 P11362 4/20 0.48
HPGD P15428 6/20 0.44
TSHR P16473 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
GAA P10253 1/20 0.42
GSK3B P49841 1/20 0.42
PLK1 P53350 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
KDM4E B2RXH2 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
ACSS2 Q9NR19 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19911356 0.89 MTNR1A (0.49) KMT2AFGFR1HPGDTSHRNPSR1
SCHEMBL19848126 0.83 KMT2A (0.45) KMT2AFGFR1HPGDTSHRNPSR1
SCHEMBL19911345 0.82 FGFR1 (0.52) KMT2AFGFR1HPGDTSHRNPSR1
SCHEMBL20489183 0.81 FGFR1 (0.52) KMT2AFGFR1HPGDTSHRNPSR1
SCHEMBL19848094 0.81 FGFR1 (0.44) KMT2AFGFR1HPGDGAARAB9A
SCHEMBL19911432 0.80 KMT2A (0.46) KMT2AFGFR1HPGDTSHRALDH1A1
SCHEMBL19848142 0.78 MAPT (0.45) KMT2AFGFR1HPGDALDH1A1MAPT
SCHEMBL19848281 0.76 F12 (0.49) NPSR1ESR1ESR2GAAALDH1A1
SCHEMBL24110390 0.76 KMT2A (0.46) KMT2AFGFR1HPGDTSHRNPSR1
SCHEMBL24110493 0.76 KMT2A (0.46) KMT2AFGFR1HPGDTSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10756394-B2 Nonaqueous electrolyte and nonaqueous secondary battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2020-08-25 US disclosed
EP-3467930-A1 NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY ASAHI KASEI KABUSHIKI KAISHA (JP) 2019-04-10 EP disclosed
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-03-01 US disclosed
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10756394-B2 Nonaqueous electrolyte and nonaqueous secondary battery BPTF, BRD4, KCNN2 KMT2A 458/4885FGFR1 1543/4885HPGD 2179/4885
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery BPTF, BRD4, KCNN2 KMT2A 458/4885FGFR1 1543/4885HPGD 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.